Novel Foods Group Reveals $500M Precision Fermentation Hub to Produce Brazzein

Novel Foods Group, an Abu Dhabi-based company, has partnered with Glatt Group, BioEngineering AG, and CB Consultancy AG to build a $500 million biotech production hub in the UAE focused on precision fermentation. The hub will initially produce brazzein, a sweet-tasting protein found in the fruit of the West African Oubli plant, offering a healthier alternative to sugar. Novel Foods Group aims to cater to the growing demand for sugar alternatives in the F&B sector, with brazzein's commercial applications set to revolutionize the market.

In addition to brazzein, other companies like Change Foods are also investing in precision fermentation in Abu Dhabi, with a focus on producing animal-free casein. Israel leads in precision fermentation developments for milk production, with companies like Imagindairy and Remilk, while government investment in the sector is significant. Precision fermentation blends traditional fermentation with biotechnology to efficiently produce various compounds like proteins, flavors, vitamins, and fats, paving the way for innovative and sustainable food products.